Reduced Neurite Arborization in Primary Dopaminergic Neurons in Autism-Like Shank3B-Deficient Mice
- PMID: 39654001
- PMCID: PMC11953188
- DOI: 10.1007/s12035-024-04652-0
Reduced Neurite Arborization in Primary Dopaminergic Neurons in Autism-Like Shank3B-Deficient Mice
Abstract
Despite many studies on dopamine changes in autism, specific alterations in midbrain dopamine neurons projecting to the striatum and cortex remain unclear. Mouse models with diverse SH3 domain and ankyrin repeat containing protein 3 (Shank3) deficiencies are used for investigating autistic symptoms and underlying neurobiological mechanisms. SHANK3 belongs to postsynaptic proteins crucial for synapse formation during development, and disruptions in SHANK3 structure could lead to impaired neurite outgrowth and altered dendritic arborization and morphology. Therefore, we aimed to investigate whether Shank3 deficiency (Shank3B) leads to changes in the morphology of primary neuronal cell cultures from dopaminergic brain regions of neonatal mouse pups and whether it results in alterations in synaptic proteins in dopaminergic nerve pathway projection areas (striatum, frontal cortex). Significantly reduced neurite outgrowth was observed in primary dopaminergic neurons from the midbrain and striatum of Shank3-deficient compared to WT mice. A decrease in Synapsin I immunofluorescence signal in the cortical neurons isolated from Shank3-deficient mice was found, although neurite arborization changes were less severe. Importantly, the deficit in the length of the longest neurite was confirmed in primary cortical neurons isolated from Shank3-deficient mice. No changes in the gene expression of synaptic proteins were observed in the striatum and frontal cortex of Shank3-deficient mice, but an altered gene expression profile of dopaminergic receptors was found. These results show structural changes of dopaminergic neurons, which may explain autistic symptomatology in the used model and provide a basis for understanding the long-term development of autistic symptoms.
Keywords: Shank3; Autism spectrum disorder; Dopaminergic neurons; Neurite outgrowth.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval: All experimental procedures followed the ethical guidelines for animal experiments and were approved by the Ethical Committee of the Faculty of Medicine, Comenius University in Bratislava, Slovak Republic. The mice were handled and cared for in accordance with the Guide for the Care and Use of Laboratory Animals (N.R.C., 1996) and the European Communities Council Directive of September 22nd, 2010 (2010/63/EU, 74). Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
Figures





Similar articles
-
Shank3 deficiency alters midbrain GABAergic neuron morphology, GABAergic markers and synaptic activity in primary striatal neurons.Mol Brain. 2024 Sep 27;17(1):71. doi: 10.1186/s13041-024-01145-y. Mol Brain. 2024. PMID: 39334399 Free PMC article.
-
Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model.Mol Cell Endocrinol. 2020 Dec 1;518:110924. doi: 10.1016/j.mce.2020.110924. Epub 2020 Jun 30. Mol Cell Endocrinol. 2020. PMID: 32619581
-
Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice.Neurochem Res. 2021 Dec;46(12):3342-3355. doi: 10.1007/s11064-021-03435-6. Epub 2021 Aug 28. Neurochem Res. 2021. PMID: 34453663
-
Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies.Neural Plast. 2016;2016:8051861. doi: 10.1155/2016/8051861. Epub 2016 Oct 4. Neural Plast. 2016. PMID: 27795858 Free PMC article. Review.
-
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.J Neurodev Disord. 2021 Nov 16;13(1):55. doi: 10.1186/s11689-021-09397-8. J Neurodev Disord. 2021. PMID: 34784886 Free PMC article. Review.
Cited by
-
Animal models of autism spectrum disorder: Insights into genetic, structural and environmental models.Vet Med (Praha). 2025 Jul 25;70(7):227-241. doi: 10.17221/87/2024-VETMED. eCollection 2025 Jul. Vet Med (Praha). 2025. PMID: 40809946 Free PMC article. Review.
-
Systems Genetics Reveals the Gene Regulatory Mechanisms of Arrb2 in the Development of Autism Spectrum Disorders.Genes (Basel). 2025 May 20;16(5):605. doi: 10.3390/genes16050605. Genes (Basel). 2025. PMID: 40428426 Free PMC article.
References
-
- Falougy HE, Filova B, Ostatnikova D, Bacova Z, Bakos J (2019) Neuronal morphology alterations in autism and possible role of oxytocin. Endocr Regul 53(1):46–54. 10.2478/enr-2019-0006 - PubMed
-
- Pavăl D (2023) The dopamine hypothesis of autism spectrum disorder: a comprehensive analysis of the evidence. Int Rev Neurobiol 173:1–42. 10.1016/bs.irn.2023.08.009 - PubMed
-
- Lu X, Song Y, Wang J, Cai Y, Peng S, Lin J, Lai B, Sun J et al (2024) Developmental dopaminergic signaling modulates neural circuit formation and contributes to autism spectrum disorder-related phenotypes. Am J Pathol S0002–9440(24)00086–5. 10.1016/j.ajpath.2024.02.014 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources